CN103520414B - Chinese medicament for treating bronchial asthma - Google Patents
Chinese medicament for treating bronchial asthma Download PDFInfo
- Publication number
- CN103520414B CN103520414B CN201310484975.1A CN201310484975A CN103520414B CN 103520414 B CN103520414 B CN 103520414B CN 201310484975 A CN201310484975 A CN 201310484975A CN 103520414 B CN103520414 B CN 103520414B
- Authority
- CN
- China
- Prior art keywords
- chinese medicament
- semen
- bronchial asthma
- percent
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the field of Chinese medicaments, and discloses a Chinese medicament for treating bronchial asthma. The Chinese medicament consists of raw medicaments including pepperweed seeds, ephedra, ginkgo seed pulp, apricot kernels, pinellia tuber, common coltsfoot flowers, white mulberry roots-barks, baical skullcap roots, safflowers, bitter oranges and radix glycyrrhizae preparata according to a certain weight proportion. The Chinese medicament has the advantages of low cost, good curative effects, high cure rate, no toxic and side effects and the like; statistics made by taking 30 days as a treatment course show that the Chinese medicament has an effective rate of 100 percent, a cure rate of 72.5 percent and an improvement rate of 27.5 percent.
Description
Technical field
the present invention relates to a kind of Chinese medicine for the treatment of bronchial asthma, belong to technical field of Chinese medicines.
Background technology
bronchial asthma is common clinical, can betide any age, but morbidity before 12 years old more than half.Clinical characters is ictal uncomfortable in chest, cough, how with the expiratory dyspnea of wheezing sound, and last for several minutes, a few hours or longer, can spontaneous remission.
primary disease belongs to the traditional Chinese medical science " asthma ", " phlegm retention " category, and its major pathogenetic factor is " expectorant ", because lying prostrate in lung in expectorant, then feels new heresy and sends out.Often be divided into stage of attack and catabasis clinically.Total Therapeutic Principle is depressed lung-energy dispersing, lowering the adverse-rising QI to resolve phlegm.
Summary of the invention
the present invention is directed to the deficiency of prior art, provide a kind of Chinese medicine for the treatment of bronchial asthma, it is characterized in that it is made up of the component of the material medicine of following weight proportion: Semen Lepidii (Semen Descurainiae) 20-30g, Herba Ephedrae (processed) 6-9g, Semen Ginkgo meat 6-9g, Semen Armeniacae Amarum 6-9g, Rhizoma Pinelliae 6-9g, Flos Farfarae 9-12g, Cortex Mori 12-15g, Radix Scutellariae 9-12g, Flos Carthami 9-12g, Fructus Aurantii 12-15g, Radix Glycyrrhizae Preparata 6-9g.
preferable amount: Semen Lepidii (Semen Descurainiae) 25g, Herba Ephedrae (processed) 9g, Semen Ginkgo meat 9g, Semen Armeniacae Amarum 9g, Rhizoma Pinelliae 9g, Flos Farfarae 10g, Cortex Mori 12g, Radix Scutellariae 9g, Flos Carthami 12g, Fructus Aurantii 12g, Radix Glycyrrhizae Preparata 6g.
pharmacology analysis: sputum is stopped up in lung, causes lung qi and must not declare freely, and sees the diseases such as uncomfortable in chest, cough with asthma, therefore first-selected heavy dose of Semen Lepidii (Semen Descurainiae) depressed lung-energy dispersing in above-mentioned prescription, inducing diuresis to remove edema is monarch drug.Herba Ephedrae (processed) lung qi dispersing is loose evil to relieving asthma, Semen Ginkgo astringing lung QI for relieving asthma and eliminating the phlegm, and is ministerial drug altogether.Semen Armeniacae Amarum, the Rhizoma Pinelliae, Flos Farfarae lowering the adverse-rising QI to subdue asthma, relieving cough and resolving phlegm; Cortex Mori, Radix Scutellariae clearing away lung-heat and sending down the abnormal ascending QI expectorant; Flos Carthami blood circulation promoting and blood stasis dispelling; Fructus Aurantii promoting the circulation of QI to alleviate the stagnation in middle-JIAO, except full, is adjuvant drug altogether.Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, for making medicine.Above drug combination, makes lung qi declare, and expectorant is warm clearly, and wind and cold must be separated, then asthma spontaneous recovery.
dosage form and usage: our pharmaceutically dosage form is decoction, is decocted in water for oral dose, potion on the one.Prescribed dose is adult's amount, and children's is cut down according to the circumstance.Decoct twice.Head is decocted and is added cold water 600ml, soaks two hours, changes slow fire and continue and decoct 20 minutes, extracting juice 100ml after intense fire boils; Two decoct heating water 600ml, change that slow fire is continuous decocts 50 minutes, extracting juice 100ml after intense fire boils.Two decoct the mixing of gained medicine juice, sooner or later within two hours after meal, respectively take 100ml, warm water delivery service.Period in a medicine avoids pungent food cold and cool food, preventing cold.
beneficial effect: Chinese medicine of the present invention has the advantages such as price is low, good effect, cure rate are high, have no side effect, with the statistics that is as the criterion 30 days courses for the treatment of of taking medicine, effective percentage 100%, cure rate 72.5%, improvement rate 27.5%.
detailed description of the invention:
below in conjunction with detailed description of the invention, the present invention will be further described:
embodiment 1: a kind of Chinese medicine for the treatment of bronchial asthma, is made up of the component of the material medicine of following weight proportion: Semen Lepidii (Semen Descurainiae) 20-30g, Herba Ephedrae (processed) 6-9g, Semen Ginkgo meat 6-9g, Semen Armeniacae Amarum 6-9g, Rhizoma Pinelliae 6-9g, Flos Farfarae 9-12g, Cortex Mori 12-15g, Radix Scutellariae 9-12g, Flos Carthami 9-12g, Fructus Aurantii 12-15g, Radix Glycyrrhizae Preparata 6-9g.
embodiment 2: a kind of Chinese medicine for the treatment of bronchial asthma, wherein the preferred weight proportioning of various material medicine is: Semen Lepidii (Semen Descurainiae) 25g, Herba Ephedrae (processed) 9g, Semen Ginkgo meat 9g, Semen Armeniacae Amarum 9g, Rhizoma Pinelliae 9g, Flos Farfarae 10g, Cortex Mori 12g, Radix Scutellariae 9g, Flos Carthami 12g, Fructus Aurantii 12g, Radix Glycyrrhizae Preparata 6g.
clinical efficacy is summed up:
one, physical data: treat patient 24 example altogether, wherein male 15 example, women 9 example; Age 5-10 year 14 examples, 10-15 year 6 examples, more than 15 years old 4 is routine; The most elder of the course of disease 10 years, the shortest person 2 years.
two, diagnostic criteria:
1, symptom: repeated relapsing is uncomfortable in chest, cough, how with the expiratory dyspnea of wheezing sound, last for several minutes or a few hours, can spontaneous remission.
2, sign: during outbreak, thorax expands, and intercostal space is full, and auscultation two lung has wheezing sound widely, has moist rale, the dimnition of cardiac sound during accompanying infection.Prolonged illness has emphysema feature.
three, efficacy assessment standard:
1, cure: clinical symptom disappearance, do not recur in 1 year.
2, take a turn for the better: clinical symptom relief, attack times obviously reduces.
four, therapeutic outcome: January of taking medicine is a course for the treatment of, the lighter one fully recovers the course for the treatment of, the severe one two recovery from illness course for the treatment of.Effective percentage 100%, cure rate 72.5%, improvement rate 27.5%.
five, model case:
case 1: Dong's ××, female, 10 years old, student, in March, 2010 went to a doctor.Head of a family Dai Shu infant 2 years cause flu cause bronchial asthma, show effect every year for several times.Dyspnea during outbreak, can not put down sleeping, gurgling with sputum.Each outbreak all needs venous transfusion or hospitalization to alleviate.This shows effect again, and symptom is the same.Requirement takes traditional Chinese medicine treatment.Give after side's medicine of the present invention takes 3 doses, symptom is obviously alleviated, following the service 5 doses, transference cure, again after treatment one course for the treatment of, follows up a case by regular visits to and does not recur so far again.
case 2: Lee's ××, female, 18 years old, in JIUYUE, 2012 was gone to a doctor.Readme suffers from bronchial asthma 3 years, recurrent exerbation, impact study.Recently occur again uncomfortable in chest, pant, therefore to examine, require to take traditional Chinese medicine treatment.Give side's medicine of the present invention to take two weeks symptoms and obviously alleviate, following the service after treatment in two weeks, follows up a case by regular visits to after 1 year and does not recur.
Claims (1)
1. treat a Chinese medicine for bronchial asthma, it is characterized in that it is made up of the component of the material medicine of following weight proportion: Semen Lepidii (Semen Descurainiae) 20-30g, Herba Ephedrae (processed) 6-9g, Semen Ginkgo meat 6-9g, Semen Armeniacae Amarum 6-9g, Rhizoma Pinelliae 6-9g, Flos Farfarae 9-12g, Cortex Mori 12-15g, Radix Scutellariae 9-12g, Flos Carthami 9-12g, Fructus Aurantii 12-15g, Radix Glycyrrhizae Preparata 6-9g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310484975.1A CN103520414B (en) | 2013-10-17 | 2013-10-17 | Chinese medicament for treating bronchial asthma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310484975.1A CN103520414B (en) | 2013-10-17 | 2013-10-17 | Chinese medicament for treating bronchial asthma |
Related Child Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410749343.8A Division CN104352691A (en) | 2013-10-17 | 2013-10-17 | Traditional Chinese medicine decoction for treating bronchial asthma |
| CN201410749232.7A Division CN104398716A (en) | 2013-10-17 | 2013-10-17 | Traditional Chinese medicine decoction for treating bronchial asthma |
| CN201410748990.7A Division CN104383182A (en) | 2013-10-17 | 2013-10-17 | Traditional Chinese medicine for treating bronchial asthma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103520414A CN103520414A (en) | 2014-01-22 |
| CN103520414B true CN103520414B (en) | 2015-01-28 |
Family
ID=49923001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310484975.1A Expired - Fee Related CN103520414B (en) | 2013-10-17 | 2013-10-17 | Chinese medicament for treating bronchial asthma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103520414B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101116730A (en) * | 2007-08-17 | 2008-02-06 | 张秀丽 | Oral Chinese traditional medicine composition for treating bronchiolectasis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1098695C (en) * | 2000-03-03 | 2003-01-15 | 马桂玲 | Chinese medicinal composition for treating asthma and preparing process thereof |
-
2013
- 2013-10-17 CN CN201310484975.1A patent/CN103520414B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101116730A (en) * | 2007-08-17 | 2008-02-06 | 张秀丽 | Oral Chinese traditional medicine composition for treating bronchiolectasis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103520414A (en) | 2014-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102872261A (en) | Application of straw berry tomato in preparing medicine for treating acute cholecystitis | |
| CN104547496B (en) | A kind of Chinese medicine composition to moisten the lung and relieve the cough and preparation method thereof | |
| CN104013919A (en) | Traditional Chinese medicine for treating angina pectoris | |
| CN104383071A (en) | Medicine composition with capability of strengthening spleen and stomach | |
| CN103211964A (en) | Chinese medicament for treating cough | |
| CN103520414B (en) | Chinese medicament for treating bronchial asthma | |
| CN102631580B (en) | Preparation method of Chinese herb for treating phlegm-heat type asthma | |
| CN104352691A (en) | Traditional Chinese medicine decoction for treating bronchial asthma | |
| CN104800772A (en) | Traditional Chinese medicine composition for treating vital-energy-depression type coronary heart disease and application of traditional Chinese medicine composition | |
| CN104491591A (en) | Health-care tea used for depression | |
| CN104027760A (en) | Traditional Chinese medicament for treating wind-phlegm in lung type asthma | |
| CN104398716A (en) | Traditional Chinese medicine decoction for treating bronchial asthma | |
| CN104383182A (en) | Traditional Chinese medicine for treating bronchial asthma | |
| CN107095977A (en) | A kind of medicament and its pharmaceutical formulation and preparation method with the malicious effect of fire row of dispelling | |
| CN105920497A (en) | Medicine for treating gastropathy and preparation method thereof | |
| CN105749103A (en) | Pharmaceutical preparation for treating narcolepsy and preparation method thereof | |
| CN105362596A (en) | Traditional Chinese medicine for treating pulmonary emphysema and preparation method thereof | |
| CN103933467A (en) | Traditional Chinese medicine composition for treating gall stone | |
| CN104258361A (en) | Traditional Chinese medicine composition for treating infantile asthma | |
| CN104524283A (en) | Use of traditional Chinese medicine composition for preparing medicine for treating chronic gastritis | |
| CN104208440A (en) | Chinese medicine for treating lung dryness and phlegm congealing type globus hysteriocus | |
| CN104784567B (en) | A kind of pharmaceutical composition for the treatment of urinary system infection | |
| CN104189315B (en) | A kind of Chinese medicine for the treatment of expectorant blood stasis type globus hystericus | |
| CN103751616B (en) | Pharmaceutical composition for the treatment of autonomic nervous dysfunction and its production and use | |
| CN104127713A (en) | Traditional Chinese medicine composition for treating vascular migraine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: QINGDAO MUNICIPAL HOSPITAL Free format text: FORMER OWNER: LIU YUNBO Effective date: 20141223 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Liu Xiuqin Inventor after: Xue Mei Inventor after: Chu Xiao Inventor after: Yu Shuhong Inventor before: Liu Yunbo |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 264400 WEIHAI, SHANDONG PROVINCE TO: 266071 QINGDAO, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: LIU YUNBO TO: LIU XIUQIN XUE MEI CHU XIAO YU SHUHONG |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20141223 Address after: Donghai Road 266071 Shandong city of Qingdao province No. 5 Applicant after: Qingdao Municipal Hospital Address before: 401, room 1, unit 5, central Longwan District, 2-1 meter East Road, Wendeng, Weihai, Shandong, Applicant before: Liu Yunbo |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150128 Termination date: 20151017 |
|
| EXPY | Termination of patent right or utility model |